Development and validation of algorithms for heart failure patient care: a Delphi study

about

Development and validation of algorithms for heart failure patient care: a Delphi study

Item

http://www.wikidata.org/entity/Q35555345

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Development and validation of algorithms for heart failure patient care: a Delphi study

@ast

Development and validation of algorithms for heart failure patient care: a Delphi study

@en

type

Item

label

Development and validation of algorithms for heart failure patient care: a Delphi study

@ast

Development and validation of algorithms for heart failure patient care: a Delphi study

@en

prefLabel

Development and validation of algorithms for heart failure patient care: a Delphi study

@ast

Development and validation of algorithms for heart failure patient care: a Delphi study

@en

P1476

Development and validation of algorithms for heart failure patient care: a Delphi study

@en

P2093

Asri Ranga

http://www.w3.org/2001/XMLSchema#string

Cynthia Priyadarshini Gopal

http://www.w3.org/2001/XMLSchema#string

Kevin Louis Joseph

http://www.w3.org/2001/XMLSchema#string

P2860

The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment

Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trial

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

A systematic review of the effects of physician specialty on the treatment of coronary disease and heart failure in the United States.

Research guidelines for the Delphi survey technique.

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study.

Evaluation of the use of evidence-based angiotensin-converting enzyme inhibitor criteria for the treatment of congestive heart failure: opportunities for pharmacists to improve patient outcomes.

Expert consensus document on beta-adrenergic receptor blockers.

Antiarrhythmics: elimination and dosage considerations in hepatic impairment.

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

P304

217-223

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.11622/SMEDJ.2014190

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Balamurugan Tangiisuran

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270000651

http://www.w3.org/2001/XMLSchema#string

P698

25532514

http://www.w3.org/2001/XMLSchema#string

P932

4415102

http://www.w3.org/2001/XMLSchema#string